DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2026
    • Delegate Registration
    • Lecture Programme
    • Speakers
    • The DDL Incubator
    • Attending Exhibitors and Sponsors
    • New Researcher Network
    • Hotel and Travel
    • Media Partners
    • Frequently Asked Questions
  • Archive
    • Conference Papers Archive
    • DDL2025
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • EPAG Workshop
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2024
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2023
      • Lecture Recordings
      • The Association of Inhalation Toxicologists – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2022
      • Lecture Recordings
      • Academy of Pharmaceutical Sciences – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2021
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Sponsors
    • Previous Years Conferences
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
    • Aerosol Society Awards
  • About
    • Gallery
    • History
    • DDL Charter
    • Committee
    • The Scientific Advisors
    • Contact
  • Associated Events
    • Annual Aerosol Science Conference
    • RDD 2027
    • USP Workshop
  • The Aerosol Society logo
Jose M. Lagaron

Jose M. Lagaron

Novel Materials and Nanotechnology for Health Applications group at CSIC

Dr. Jose M. Lagaron is a Full Professor, Founder, and Group Leader of the Novel Materials and Nanotechnology for Health Applications group at CSIC (Spanish National Research Council). He also served as Founder, Chairman, CEO and CSO of BioNanoPharma S.L. and is currently Founder, Chairman and CSO. According to Scopus, Dr. Lagaron has authored 373 peer-reviewed publications, holds 78 patents, and has an h-index of 83—reflecting his significant impact in the fields of biopolymers and nanobiotechnology. He is a member of the editorial boards of several prominent scientific journals and currently serves as Vice-President of BIOVAL, the Bioregion of the Valencian Community in Spain. In addition to his academic and executive roles, Dr. Lagaron has founded multiple nanobiotech spin-offs, including Bioinicia S.L. and BioNanoPharma S.L., contributing to the translation of advanced technologies into commercial applications.

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2026 Drug Delivery to the Lungs Website design: definingdesign.co.uk